Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bonferroni

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Haematology|March 1, 1994
Scleroderma and hairy-cell leukemiaG B Cavallero, M Bonferroni, A Gallamini, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Autocrine or paracrine models of cytokine production and utilization in B-cell chronic lymphocytic leukaemiaR Foa, M Giovarelli, M T Fierro, et al.
Recenti Progressi in Medicina|September 1, 1990
[Pleural effusion in a case of non-Hodgkin's lymphoma: diagnostic use of molecular analysis]G B Cavallero, M Bonferroni, P F di Celle, et al.
Leukemia & Lymphoma|April 17, 2010
Lymphokine Activated Killer (LAK) Cells Inhibit the in vitro Growth of Myeloid and Erythroid Progenitor Cells Via the Release of Tumor Necrosis Factor-AlphadaggerG Bellone, M T Fierro, X S Liao, et al.
Blood Cells|January 1, 1987
Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2)R Foa, M T Fierro, M Giovarelli, et al.
Blood|August 15, 1991
Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active diseaseR Foa, M T Fierro, A Cesano, et al.
European Journal of Haematology|May 1, 1989
Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cellsP Lista, M T Fierro, X S Liao, et al.
Leukemia|April 1, 1987
Effect of alpha-interferon on the immune system of patients with hairy cell leukemiaR Foa, M T Fierro, P Lusso, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
Bone Marrow Transplantation|January 1, 1989
Lymphokine activated killer (LAK) activity in lymphoproliferative disordersR Foa, M T Fierro, D Raspadori, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Haematology|March 1, 1994
Scleroderma and hairy-cell leukemiaG B Cavallero, M Bonferroni, A Gallamini, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Autocrine or paracrine models of cytokine production and utilization in B-cell chronic lymphocytic leukaemiaR Foa, M Giovarelli, M T Fierro, et al.
Recenti Progressi in Medicina|September 1, 1990
[Pleural effusion in a case of non-Hodgkin's lymphoma: diagnostic use of molecular analysis]G B Cavallero, M Bonferroni, P F di Celle, et al.
Leukemia & Lymphoma|April 17, 2010
Lymphokine Activated Killer (LAK) Cells Inhibit the in vitro Growth of Myeloid and Erythroid Progenitor Cells Via the Release of Tumor Necrosis Factor-AlphadaggerG Bellone, M T Fierro, X S Liao, et al.
Blood Cells|January 1, 1987
Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2)R Foa, M T Fierro, M Giovarelli, et al.
Blood|August 15, 1991
Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active diseaseR Foa, M T Fierro, A Cesano, et al.
European Journal of Haematology|May 1, 1989
Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cellsP Lista, M T Fierro, X S Liao, et al.
Leukemia|April 1, 1987
Effect of alpha-interferon on the immune system of patients with hairy cell leukemiaR Foa, M T Fierro, P Lusso, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
Bone Marrow Transplantation|January 1, 1989
Lymphokine activated killer (LAK) activity in lymphoproliferative disordersR Foa, M T Fierro, D Raspadori, et al.
Pageof 2